ENTITY
Nektar Therapeutics

Nektar Therapeutics (NKTR US)

18
Analysis
Health Care • United States
Nektar Therapeutics is a clinical-stage biopharmaceutical company which develops a pipeline of drug candidates that utilize company platforms. The Company's product pipeline is comprised of early to late stage drug candidates across a number of therapeutic areas including oncology, pain, anti-infectives, anti-viral and immunology.
more
•25 Sep 2025 10:35

Primer: Nektar Therapeutics (NKTR US) - Sep 2025

Nektar Therapeutics is a clinical-stage biopharmaceutical company at a pivotal juncture, with its future success largely dependent on its lead...

Logo
377 Views
Share
x